Ludwig Hantson

CEO, Alexion Pharmaceuticals Inc.

Hantson is in his current position since 2017. Previously, he was president and CEO of Baxalta Inc. He led Baxalta's spin-off as a public company from Baxter in 2015. He joined Baxter in 2010 as president of Baxter BioScience, and previously held leadership roles with Novartis AG and Johnson & Johnson.

Relationships Interlocks Giving Data

Business Positions

Alexion Pharmaceuticals, Inc.

• CEO ('17→?)

Baxter International, Inc. Fortune 500 American health care company based in Illinois

• Corporate Vice President, President - Bioscience ('10→'15)

Board Memberships

Hologic

• Board Member ('19→?)

Updated over 4 years ago

Types	Person, Business Person
Aliases	Mr Ludwig N. Hantson

Sec - Edgar

corporate-mapping-project